Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: A contribution to the current debate on disease pathogenesis

Progress in Neurobiology

Volumn 86, Issue 4, 2008, Pages 406-416

  Casaccia Bonnefil, Patrizia ^a   Pandozy, Giovanna ^c   Mastronardi, Fabrizio ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c NONE

Author keywords

Chromatin; DNA methylation; Epigenetics; Histone; Multiple sclerosis

Indexed keywords

GLUCOCORTICOID; HISTONE; HISTONE DEACETYLASE INHIBITOR; LYSINE; TRICHOSTATIN A;

DEMYELINATING DISEASE; DISEASE COURSE; DNA METHYLATION; DRUG ANTAGONISM; DRUG MECHANISM; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPATHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; ANIMAL; BRAIN; EVALUATION; GENETIC EPIGENESIS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; EPIGENESIS, GENETIC; EVALUATION STUDIES AS TOPIC; HUMANS; MULTIPLE SCLEROSIS;

EID: 57049160500     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2008.09.012     Document Type: Review

References (202)

1. Adcock I.M., Ito K., and Barnes P.J. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD 2 (2005) 445-455
2. Albert M., Antel J., Bruck W., and Stadelmann C. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 17 (2007) 129-138
3. Anand R., and Marmorstein R. Structure and mechanism of lysine specific demethylase enzymes. J. Biol. Chem. 282 (2007) 35425-35429
4. Ashraf S.I., and Ip Y.T. Transcriptional control: repression by local chromatin modification. Curr. Biol. 8 (1998) R683-686
5. Bai G., Sheng N., Xie Z., Bian W., Yokota Y., Benezra R., Kageyama R., Guillemot F., and Jing N. Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1. Dev. Cell 13 (2007) 283-297
6. Bannister A.J., and Kouzarides T. Reversing histone methylation. Nature 436 (2005) 1103-1106
7. Bannister A.J., Schneider R., and Kouzarides T. Histone methylation: dynamic or static?. Cell 109 (2002) 801-806
8. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55 (2004) 458-468
9. Barnett M.H., and Sutton I. The pathology of multiple sclerosis: a paradigm shift. Curr. Opin. Neurol. 19 (2006) 242-247
10. Bauer U.M., Daujat S., Nielsen S.J., Nightingale K., and Kouzarides T. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 3 (2002) 39-44
11. Becher B., Bechmann I., and Greter M. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J. Mol. Med. (Berlin, Germany) 84 (2006) 532-543
12. Bedford M.T., and Richard S. Arginine methylation an emerging regulator of protein function. Mol. Cell 18 (2005) 263-272
13. Belogurov A.A., Kurkova I.N., Friboulet A., Thomas D., Misikov V.K., Zakharova M.Y., Suchov S.V., Kotov S.V., Alehin A.I., Avalle B., Souslova E.A., Norse H., Gabibov A.G., and Ponomarenko N.A. Recognition and degradation of myelin basic proteins by serum autoantibodies: novel biomarkers for multiple sclerosis. J. Immunol. 180 (2008) 1258-1267
14. Berger S.L. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12 (2002) 142-148
15. Bird A.P., and Wolffe A.P. Methylation-induced repression-belts, braces, and chromatin. Cell 99 (1999) 451-454
16. Boisvert F.M., Chenard C.A., and Richard S. Protein interfaces in signaling regulated by arginine methylation. Sci. STKE 2005 (2005) re2
17. Brown R., and Brockes J.P. Identification and expression of a regeneration-specific homeobox gene in the newt limb blastema. Development (Cambridge, England) 111 (1991) 489-496
18. Bruck W., Kuhlmann T., and Stadelmann C. Remyelination in multiple sclerosis. J. Neurol. Sci. 206 (2003) 181-185
19. Brynedal B., Duvefelt K., Jonasdottir G., Roos I.M., Akesson E., Palmgren J., and Hillert J. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2 (2007) e664
20. Calabresi P.A., Giovannoni G., Confavreux C., Galetta S.L., Havrdova E., Hutchinson M., Kappos L., Miller D.H., O'Connor P.W., Phillips J.T., Polman C.H., Radue E.W., Rudick R.A., Stuart W.H., Lublin F.D., Wajgt A., Weinstock-Guttman B., Wynn D.R., Lynn F., and Panzara M.A. The incidence and significance of anti-natalizumab antibodies. Results from AFFIRM and SENTINEL. Neurology 69 (2007) 1391-1403
21. Camelo S., Iglesias A.H., Hwang D., Due B., Ryu H., Smith K., Gray S.G., Imitola J., Duran G., Assaf B., Langley B., Khoury S.J., Stephanopoulos G., De Girolami U., Ratan R.R., Ferrante R.J., and Dangond F. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 164 (2005) 10-21
22. Cao L., Goodin R., Wood D., Moscarello M.A., and Whitaker J.N. Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein. Biochemistry 38 (1999) 6157-6163
23. Carotenuto A., D'Ursi A.M., Mulinacci B., Paolini I., Lolli F., Papini A.M., Novellino E., and Rovero P. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis. J Med Chem. 49 (2006) 5072-5079
24. Casaccia-Bonnefil P. and Shen S. 2008. Histone acetylation and timing of neural progenitor differentiation. In: Encyclopedia of Neuroscience. Edited by U. Windhorst, M. Binder and N. Hirokawa. Heidelberg, Springer Verlag Publishers.
25. Ceccatelli S., Tamm C., Zhang Q., and Chen M. Mechanisms and modulation of neural cell damage induced by oxidative stress. Physiol. Behav. 92 (2007) 87-92
26. Chang A., Nishiyama A., Peterson J., Proneas J., and Trapp B.D. NG2-positive oligodendrocyte progenitor cells in human brain and multiple sclerosis lesions. J. Neurosci. 20 (2000) 6404-6412
27. Chaudhuri A., and Behan P.O. Multiple sclerosis is not an autoimmune disease. Arch. Neurol. 61 (2004) 1610-1612
28. Chen A.M., Khanna N., Stohlman S.A., and Bergmann C.C. Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis. J. Virol. 79 (2005) 4700-4708
29. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., and Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 284 (1999) 2174-2177
30. Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A., Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., and Allis C.D. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113 (2003) 507-517
31. Choi J.H., Oh S.W., Kang M.S., Kwon H.J., Oh G.T., and Kim D.Y. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy 35 (2005) 89-96
32. Compston A. Limiting and repairing the damage in multiple sclerosis. Schweizerische Medizinische Wochenschrift 123 (1993) 1145-1152
33. Compston A. Brain repair. J. Intern. Med. 237 (1995) 127-134
34. Covacu R., Danilov A.I., Rasmussen B.S., Hallen K., Moe M.C., Lobell A., Johansson C.B., Svensson M.A., Olsson T., and Brundin L. Nitric oxide exposure diverts neural stem cell fate from neurogenesis towards astrogliogenesis. Stem Cells 24 (2006) 2792-2800
35. Cunliffe V.T., and Casaccia-Bonnefil P. Histone deacetylase 1 is essential for oligodendrocyte specification in the zebrafish CNS. Mech. Dev. 123 (2006) 24-30
36. D'Souza C.A., and Moscarello M.A. Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope. Neurochem. Res. 31 (2006) 1045-1054
37. D'Souza C.A., Wood D.D., She Y.M., and Moscarello M.A. Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry. Biochemistry 44 (2005) 12905-12913
38. Dai B., and Rasmussen T.P. Global epiproteomic signatures distinguish ES cells from differentiated cells. Stem Cells (2007)
39. Dangond F., and Gullans S.R. Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. Biochem. Biophys. Res. Commun. 247 (1998) 833-837
40. Davie J.K., and Dent S.Y. Transcriptional control: an activating role for arginine methylation. Curr. Biol. 12 (2002) R59-61
41. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., and van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370 (2003) 737-749
42. Delgado S., and Sheremata W.A. The role of CD4+ T-cells in the development of MS. Neurol. Res. 28 (2006) 245-249
43. Denman R.B. PAD: the smoking gun behind arginine methylation signaling?. Bioessays 27 (2005) 242-246
44. Dietrich J., Blumberg B.M., Roshal M., Baker J.V., Hurley S.D., Mayer-Proschel M., and Mock D.J. Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J. Neurosci. 24 (2004) 4875-4883
45. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., Kim H.J., and Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178 (2007) 6092-6099
46. Elices M.J. A balancing act-making the right choices in anti-inflammatory drug development. Curr. Opin. Investig. Drugs 8 (2007) 362-363
47. Finch P.R., and Moscarello M.A. A myelin protein fraction extracted with thioethanol. Brain Res. 42 (1972) 177-187
48. Forsberg E.C., and Bresnick E.H. Histone acetylation beyond promoters: long-range acetylation patterns in the chromatin world. Bioessays 23 (2001) 820-830
49. Forte G.I., Ragonese P., Salemi G., Scola L., Candore G., D'Amelio M., Crivello A., Di Benedetto N., Nuzzo D., Giacalone A., Lio D., and Caruso C. Search for genetic factors associated with susceptibility to multiple sclerosis. Ann. N. Y. Acad. Sci. 1067 (2006) 264-269
50. Genain C.P., Cannella B., Hauser S.L., and Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5 (1999) 170-175
51. Gestri D., Baldacci L., Taiuti R., Galli E., Maggi E., Piccinni M.P., Vergelli M., and Massacesi L. Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system. J Neurol Neurosurg Psychiatry. 70 (2001) 767-772
52. Goll M.G., and Bestor T.H. Histone modification and replacement in chromatin activation. Genes Dev 16 (2002) 1739-1742
53. Gregory P.D., Wagner K., and Horz W. Histone acetylation and chromatin remodeling. Exp. Cell Res. 265 (2001) 195-202
54. Guimaraes J.P., Klaczko L.B., Hirano K., Vaz E.M., and Miguel M.R. Reappearance of embryonal antigens in planarian regenerates. Rev. Brasil. Pesquisas Med. Biol. 8 (1975) 255-259
55. Hafler D.A. Multiple sclerosis. J. Clin. Investig. 113 (2004) 788-794
56. Hafler D.A., Slavik J.M., Anderson D.E., O'Connor K.C., De Jager P., and Baecher-Allan C. Multiple sclerosis. Immunol. Rev. 204 (2005) 208-231
57. Hake S.B., Xiao A., and Allis C.D. Linking the epigenetic 'language' of covalent histone modifications to cancer. Br. J. Cancer 96 Suppl. (2007) R31-R39
58. Hansen T., Skytthe A., Stenager E., Petersen H.C., Bronnum-Hansen H., and Kyvik K.O. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult. Scler. (Houndmills, Basingstoke, England) 11 (2005) 504-510
59. Hansen T., Skytthe A., Stenager E., Petersen H.C., Kyvik K.O., and Bronnum-Hansen H. Risk for multiple sclerosis in dizygotic and monozygotic twins. Mult. Scler. (Houndmills, Basingstoke, England) 11 (2005) 500-503
60. He Y., Dupree J., Wang J., Sandoval J., Li J., Liu H., Shi Y., Nave K.A., and Casaccia-Bonnefil P. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55 (2007) 217-230
61. Herrera B.M., Ramagopalan S.V., Orton S., Chao M.J., Yee I.M., Sadovnick A.D., and Ebers G.C. Parental transmission of MS in a population-based Canadian cohort. Neurology 69 (2007) 1208-1212
62. Herrero-Herranz E., Pardo L.A., Bunt G., Gold R., Stuhmer W., and Linker R.A. Reexpression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation. Am. J. Pathol. 171 (2007) 589-598
63. Holmqvist P., Wallberg M., Hammar M., Landtblom A.M., and Brynhildsen J. Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 54 (2006) 149-153
64. Hsieh J., Nakashima K., Kuwabara T., Mejia E., and Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16659-16664
65. Ito K., Yamamura S., Essilfie-Quaye S., Cosio B., Ito M., Barnes P.J., and Adcock I.M. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med. 203 (2006) 7-13
66. Jason L.J., Moore S.C., Lewis J.D., Lindsey G., and Ausio J. Histone ubiquitination: a tagging tail unfolds?. Bioessays 24 (2002) 166-174
67. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., and Brosnan C.F. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8 (2002) 1115-1121
68. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68 (2004) 1145-1155
69. Kaminsky Z., Wang S.C., and Petronis A. Complex disease, gender and epigenetics. Ann. Med. 38 (2006) 530-544
70. Kaneko S., Wang J., Kaneko M., Yiu G., Hurrell J.M., Chitnis T., Khoury S.J., and He Z. Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J. Neurosci. 26 (2006) 9794-9804
71. Kantarci O.H., Barcellos L.F., Atkinson E.J., Ramsay P.P., Lincoln R., Achenbach S.J., De Andrade M., Hauser S.L., and Weinshenker B.G. Men transmit MS more often to their children vs women: the Carter effect. Neurology 67 (2006) 305-310
72. Kaplan R.N., Psaila B., and Lyden D. Niche-to-niche migration of bone-marrow-derived cells. Trends Mol. Med. 13 (2007) 72-81
73. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., Khoury S.J., and Weiner H.L. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. 177 (2006) 4196-4202
74. Kassiotis G., Pasparakis M., Kollias G., and Probert L. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis. Eur. J. Immunol. 29 (1999) 774-780
75. Klawiter E.C., and Cross A.H. B cells: no longer the nondominant arm of multiple sclerosis. Curr. Neurol. Neurosci. Rep. 7 (2007) 231-238
76. Klose R.J., and Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8 (2007) 307-318
77. Knudsen G.P., Harbo H.F., Smestad C., Celius E.G., Akesson E., Oturai A., Ryder L.P., Spurkland A., and Orstavik K.H. X chromosome inactivation in females with multiple sclerosis. Eur. J. Neurol. 14 (2007) 1392-1396
78. Koch M.W., Mostert J.P., de Vries J.J., and De Keyser J. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 68 (2007) 1163 (author reply 1163-1164)
79. Komoly S. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. Ideggyogyaszati Szemle 58 (2005) 40-43
80. Kondo T., and Raff M. Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells. Genes Dev. 18 (2004) 2963-2972
81. Kornek B., and Lassmann H. Neuropathology of multiple sclerosis-new concepts. Brain Res Bull 61 (2003) 321-326
82. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., Backstrom B.T., Sobel R.A., Wucherpfennig K.W., Strom T.B., Oukka M., and Kuchroo V.K. Myelinspecific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13 (2007) 423-431
83. Kouzarides T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12 (2002) 198-209
84. Kouzarides T. Chromatin modifications and their function. Cell 128 (2007) 693-705
85. Kubicek S., and Jenuwein T. A crack in histone lysine methylation. Cell 119 (2004) 903-906
86. Kutzelnigg A., Faber-Rod J.C., Bauer J., Lucchinetti C.F., Sorensen P.S., Laursen H., Stadelmann C., Bruck W., Rauschka H., Schmidbauer M., and Lassmann H. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol. (Zurich, Switzerland) 17 (2007) 38-44
87. Lachner M., and Jenuwein T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14 (2002) 286-298
88. Lamb B.T., Satyamoorthy K., Li L., Solter D., and Howe C.C. CpG methylation of an endogenous retroviral enhancer inhibits transcription factor binding and activity. Gene Exp. 1 (1991) 185-196
89. Lamensa J.W., and Moscarello M.A. Deimination of human myelin basic protein by a peptidylarginine deiminase from bovine brain. J. Neurochem. 61 (1993) 987-996
90. Lassmann H., Raine C.S., Antel J., and Prineas J.W. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J. Neuroimmunol. 86 (1998) 213-217
91. Linker R., Lee D.H., Siglienti I., and Gold R. Is there a role for neurotrophins in the pathology of multiple sclerosis?. J. Neurol. 254 Suppl. 1 (2007) I33-I40
92. Liu A., Muggironi M., Marin-Husstege M., and Casaccia-Bonnefil P. Oligodendrocyte process outgrowth in vitro is modulated by epigenetic regulation of cytoskeletal severing proteins. Glia. 44 (2003) 264-274
93. Liu A., Stadelmann C., Moscarello M., Bruck W., Sobel A., Mastronardi F.G., and Casaccia-Bonnefil P. Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders. J. Neurosci. 25 (2005) 737-747
94. Liu A., Li J., Marin-Husstege M., Kageyama R., Fan Y., Gelinas C., and Casaccia-Bonnefil P. A molecular insight of Hes5-dependent inhibition of myelin gene expression: old partners and new players. EMBO J. 25 (2006) 4833-4842
95. Lopatinskaya L., Zwemmer J., Uitdehaag B., Lucas K., Polman C., and Nagelkerken L. Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years. Mult. Scler. (Houndmills, Basingstoke, England) 12 (2006) 704-709
96. Lu Q., Qiu X., Hu N., Wen H., Su Y., and Richardson B.C. Epigenetics, disease, and therapeutic interventions. Ageing Res. Rev. 5 (2006) 449-467
97. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
98. Ludwin S.K. The pathogenesis of multiple sclerosis: relating human pathology to experimental studies. J. Neuropathol. Exp. Neurol. 65 (2006) 305-318
99. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallstrom E., Khademi M., Oturai A., Ryder L.P., Saarela J., Harbo H.F., Celius E.G., Salter H., Olsson T., and Hillert J. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39 (2007) 1108-1113
100. Lyssiotis C.A., Walker J., Wu C., Kondo T., Schultz P.G., and Wu X. Inhibition of histone deacetylase activity induces developmental plasticity in oligodendrocyte precursor cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14982-14987
101. Madhavan L., Ourednik V., and Ourednik J. Increased "vigilance" of antioxidant mechanisms in neural stem cells potentiates their capability to resist oxidative stress. Stem Cells 24 (2006) 2110-2119
102. Marin-Husstege M., Muggironi M., Liu A., and Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J. Neurosci. 22 (2002) 10333-10345
103. Mastronardi F.G., Min W., Wang H., Winer S., Dosch M., Boggs J.M., and Moscarello M.A. Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J. Immunol. 172 (2004) 6418-6426
104. Mastronardi F.G., and Moscarello M.A. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis. J. Neurosci. Res. 80 (2005) 301-308
105. Mastronardi F.G., Noor A., Wood D.D., Paton T., and Moscarello M.A. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J. Neurosci. Res. 85 (2007) 2006-2016
106. Mastronardi F.G., Tsui H., Winer S., Wood D.D., Selvanantham T., Galligan C., Fish E.N., Dosch H.M., and Moscarello M.A. Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases. Mult. Scler. (Houndmills, Basingstoke, England) 13 (2007) 596-609
107. Mastronardi F.G., Wood D.D., Mei J., Raijmakers R., Tseveleki V., Dosch H.M., Probert L., Casaccia-Bonnefil P., and Moscarello M.A. Increased citrullination of histone [3H] in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J. Neurosci. 26 (2006) 11387-11396
108. McDole J., Johnson A.J., and Pirko I. The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis. Neurol. Res. 28 (2006) 256-261
109. McLaurin J., Ackerley C.A., and Moscarello M.A. Localization of basic proteins in human myelin. J. Neurosci. Res. 35 (1993) 618-628
110. McLaurin J., Hafler D., and Antel J.P. Reactivity of normal T-cell lines to MBP isolated from normal and multiple sclerosis white matter. J. Neurol. Sci. 128 (1995) 205-211
111. Mendez-Fernandez Y.V., Johnson A.J., Rodriguez M., and Pease L.R. Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide. Eur. J. Immunol. 33 (2003) 2501-2510
112. Merkler D., Horvath E., Bruck W., Zinkernagel R.M., Del la Torre J.C., and Pinschewer D.D. "Viral deja vu" elicits organ-specific immune disease independent of reactivity to self. J. Clin. Investig. 116 (2006) 1254-1263
113. Michan S., and Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem. J. 404 (2007) 1-13
114. Moreira J.M., Scheipers P., and Sorensen P. The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. BMC Cancer 3 (2003) 30
115. Moscarello M.A., Brady G.W., Fein D.B., Wood D.D., and Cruz T.F. The role of charge microheterogeneity of basic protein in the formation and maintenance of the multilayered structure of myelin: a possible role in multiple sclerosis. J. Neurosci. Res. 15 (1986) 87-99
116. Moscarello M.A., Mastronardi F.G., and Wood D.D. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem. Res. 32 (2007) 251-256
117. Moscarello M.A., Pritzker L., Mastronardi F.G., and Wood D.D. Peptidylarginine deiminase: a candidate factor in demyelinating disease. J. Neurochem. 81 (2002) 335-343
118. Moscarello M.A., Wood D.D., Ackerley C., and Boulias C. Myelin in multiple sclerosis is developmentally immature. J. Clin. Investig. 94 (1994) 146-154
119. Muller-Hilke B., and Mitchison N.A. The role of HLA promoters in autoimmunity. Curr. Pharm. Des. 12 (2006) 3743-3752
120. Murray P.D., McGavern D.B., Sathornsumetee S., and Rodriguez M. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis. Brain 124 (2001) 1403-1416
121. Musse A.A., Boggs J.M., and Harauz G. Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 4422-4427
122. Musse A.A., and Harauz G. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS. Int Rev Neurobiol. 79 (2007) 149-172
123. Nikbin B., Bonab M.M., Khosravi F., and Talebian F. Role of B cells in pathogenesis of multiple sclerosis. Int. Rev. Neurobiol. 79 (2007) 13-42
124. Nonkwelo C.B., and Long W.K. Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation. Virology 197 (1993) 205-215
125. Odeberg J., Wolmer N., Falci S., Westgren M., Seiger A., and Soderberg-Naucler C. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol. 80 (2006) 8929-8939
126. Ogle B.M., Cascalho M., and Platt J.L. Biological implications of cell fusion. Nat. Rev. 6 (2005) 567-575
127. Ohtani-Fujita N., Fujita T., Aoike A., Osifchin N.E., Robbins P.D., and Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumorsuppressor gene. Oncogene 8 (1993) 1063-1067
128. Olsson T. New era for MS treatment, Severe setback when it comes to enthusiasm-highly effective agent caused serious adverse effects. Lakartidningen 103 (2006) 1282-1283
129. Pahlich S., Zakaryan R.P., and Gehring H. Protein arginine methylation: cellular functions and methods of analysis. Biochim. Biophys. Acta 1764 (2006) 1890-1903
130. Pal S., Vishwanath S.N., Erdjument-Bromage H., Tempst P., and Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol. Cell Biol. 24 (2004) 9630-9645
131. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., Sorensen P.S., Bruck W., Lucchinetti C., and Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129 (2006) 3165-3172
132. Petronis A. Epigenetics and twins: three variations on the theme. Trends Genet. 22 (2006) 347-350
133. Pittock S.J., and Lucchinetti C.F. The pathology of MS: new insights and potential clinical applications. Neurologist 13 (2007) 45-56
134. Poser C.M. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect. Clin. Neurol. Neurosurg. 108 (2006) 227-233
135. Prineas J.W., and Connell F. Remyelination in multiple sclerosis. Ann. Neurol. 5 (1979) 22-31
136. Prineas J.W., Kwon E.E., ChoES, and Sharer L.R. Continual breakdown and regeneration of myelin in multiple sclerosis plaques. Ann. N. Y. Acad. Sci. 436 (1984) 11-32
137. Prineas J.W., Barnard R.O., Revesz T., Kwon E.E., Sharer L., and Cho E.S. Multiple sclerosis. Pathology of recurrent lesions. Brain 116 Pt 3 (1993) 681-693
138. Pritzker L.B., Joshi S., Gowan J.J., Harauz G., and Moscarello M.A. Deimination of myelin basic protein 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 39 (2000) 5374-5381
139. Ptashne M. On the use of the word 'epigenetic'. Curr. Biol. 17 (2007) R233-236
140. Raijmakers R., Zendman A.J., Egberts W.V., Vossenaar E.R., Raats J., Soede-Huijbregts C., Rutjes F.P., van Veelen P.A., Drijfhout J.W., and Pruijn G.J. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J Mol Biol. 367 (2007) 1118-1129
141. Raine C.S., and Scheinberg L.C. On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol. 20 (1988) 189-201
142. Raine C.S., and Wu E. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol. 52 (1993) 199-204
143. Rakyan V.K., Hildmann T., Novik K.L., Lewin J., Tost J., Cox A.V., Andrews T.D., Howe K.L., Otto T., Olek A., Fischer J., Gut I.G., Berlin K., and Beck S. DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol. 2 (2004) e405
144. Rice J.C., and Allis C.D. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol. 13 (2001) 263-273
145. Richards E.J. Chromatin methylation: who's on first?. Curr. Biol. 12 (2002) R694-695
146. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassmann H., Bruck W., Mandler R.N., Weinshenker B.G., Pittock S.J., Wingerchuk D.M., and Lucchinetti C.F. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130 (2007) 1194-1205
147. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu. Rev. Biochem. 70 (2001) 81-120
148. Ruthenburg A.J., Allis C.D., and Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol. Cell 25 (2007) 15-30
149. Savard P., Gates P.B., and Brockes J.P. Position dependent expression of a homeobox gene transcript in relation to amphibian limb regeneration. EMBO J. 7 (1988) 4275-4282
150. Savard P., and Tremblay M. Differential regulation of Hox C6 in the appendages of adult urodeles and anurans. J. Mol. Biol. 249 (1995) 879-889
151. Sawcer S. A new era in the genetic analysis of multiple sclerosis. Curr. Opin. Neurol. 19 (2006) 237-241
152. Sawcer S., and Compston A. Multiple sclerosis: light at the end of the tunnel. Eur. J. Hum. Genet. 14 (2006) 257-258
153. Schuettengruber B., Chourrout D., Vervoort M., Leblanc B., and Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 128 (2007) 735-745
154. Shen S., Li J., and Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J. Cell Biol. 169 (2005) 577-589
155. Shen S., and Casaccia-Bonnefil P. Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease. J. Mol. Neurosci. 35 (2008) 13-22
156. Shen S., Liu A., Li J., Wolubah C., and Casaccia-Bonnefil P. Epigenetic memory loss in aging oligodendrocytes in the corpus callosum. Neurobiol. Aging 29 (2008) 452-463
157. Shen S., Sandoval J., Swiss V.A., Li J., Dupree J., Franklin R.J., and Casaccia-Bonnefil P. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci. 11 (2008) 1024-1034
158. Sheremata W.A., Jy W., Delgado S., Minagar A., McLarty J., and Ahn Y. Interferon beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis. J. Neuroinflamm. 3 (2006) 23
159. Shiio Y., and Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13225-13230
160. Skov S., Rieneck K., Bovin L.F., Skak K., Tomra S., Michelsen B.K., and Odum N. Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression. Blood 101 (2003) 1430-1438
161. Sospedra M., and Martin R. Immunology of multiple sclerosis. Ann. Rev. Immunol. 23 (2005) 683-747
162. Spencer V.A., and Davie J.R. Role of covalent modifications of histones in regulating gene expression. Gene 240 (1999) 1-12
163. Stavropoulos P., and Hoelz A. Lysine-specific demethylase 1 as a potential therapeutic target. Exp. Opin. Ther. Targets 11 (2007) 809-820
164. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
165. Strahl B.D., Briggs S.D., Brame C.J., Caldwell J.A., Koh S.S., Ma H., Cook R.G., Shabanowitz J., Hunt D.F., Stallcup M.R., and Allis C.D. Methylation of histone [4H] at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1. Curr. Biol. 11 (2001) 996-1000
166. Stubbe J. Binding site revealed of nature's most beautiful cofactor. Science (New York, NY) 266 (1994) 1663-1664
167. Su R.C., Becker A.B., Kozyrskyj A.L., and Hayglass K.T. Epigenetic regulation of established human type 1 versus type 2 cytokine responses. J. Allergy Clin. Immunol. 121 (2008) 57-63 e53
168. Suuronen T., Huuskonen J., Pihlaja R., Kyrylenko S., and Salminen A. Regulation of microglial inflammatory response by histone deacetylase inhibitors. J. Neurochem. 87 (2003) 407-416
169. Szyf M. DNA methylation properties: consequences for pharmacology. Trends Pharmacol. Sci. 15 (1994) 233-238
170. Szyf M., McGowan P., and Meaney M.J. The social environment and the epigenome. Environ. Mol. Mutagen. 49 (2008) 46-60
171. Tabancay Jr. A.P., and Forsburg S.L. Eukaryotic DNA replication in a chromatin context. Curr. Top. Dev. Biol. 76 (2006) 129-184
172. Takeuchi T., Watanabe Y., Takano-Shimizu T., and Kondo S. Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev. Dynam. 235 (2006) 2449-2459
173. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., and Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann. N. Y. Acad. Sci. 983 (2003) 84-100
174. Thompson P.R., and Fast W. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock?. ACS Chem. Biol. 1 (2006) 433-441
175. Tomassini V., and Pozzilli C. Sex hormones: a role in the control of multiple sclerosis?. Exp. Opin. Pharmacother. 7 (2006) 857-868
176. Tomassini V., DeGiglio M., Reindl P., Russo I., Pestalozz P., Pantano T., Berger T., and Pozzilli C. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult. Scler. 13 (2007) 1086-1094
177. Tranquill L.R., Cao L., Ling N.C., Kalbacher H., Martin R.M., and Whitaker J.N. Enhanced T cell responsiveness to citrulline-containing myelin basic protein in Multiple Sclerosis. Mult. Scler. 6 (2000) 220-225
178. Turner B.M. Histone acetylation and an epigenetic code. Bioessays 22 (2000) 836-845
179. Vanderlocht J., Hellings N., Hendriks J.J., and Stinissen P. The ambivalent nature of T cell infiltration in the central nervous system of patients with multiple sclerosis. Crit. Rev. Immunol. 27 (2007) 1-13
180. Vossenaar E.R., Zendman A.J., van Venrooij W.J., and Pruijn G.J. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25 (2003) 1106-1118
181. Vukusic S., and Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin. Neurol. Neurosurg. 108 (2006) 266-270
182. Wade P.A. Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum. Mol. Genet. 10 (2001) 693-698
183. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., and Zhang Y. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293 (2001) 853-857
184. Wang S.Z., Dulin J., Wu H., Hurlock E., Lee S.E., Jansson K., and Lu Q.R. An oligodendrocyte-specific zinc-finger transcription regulator cooperates with Olig2 to promote oligodendrocyte differentiation. Development (Cambridge, England) 133 (2006) 3389-3398
185. Wang S., Sdrulla A.D., diSibio G., Bush G., Nofziger D., Hicks C., Weinmaster G., and Barres B.A. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21 (1998) 63-75
186. Wang Y., Wysocka J., Sayegh J., Lee Y.H., Perlin J.R., Leonelli L., Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S., Stallcup M.R., Allis C.D., and Coonrod S.A. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306 (2004) 279-283
187. Weaver I.C., Meaney M.J., and Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3480-3485
188. Willer C.J., Dyment D.A., Risch N.J., Sadovnick A.D., and Ebers G.C. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12877-12882
189. Wilson J.R. Targeting the JMJD2A histone lysine demethylase. Nat. Struct. Mol. Biol. 14 (2007) 682-684
190. Wizenmann A., and Bahr M. Growth characteristics of ganglion cell axons in the developing and regenerating retino-tectal projection of the rat. Cell Tissue Res. 290 (1997) 395-403
191. Wolswijk G. Oligodendrocyte survival. loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123 (2000) 105-115
192. Wood D.D., Bilbao J.M., O'Connors P., and Moscarello M.A. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann. Neurol. 40 (1996) 18-24
193. Wood D.D., and Moscarello M.A. The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein. J. Biol. Chem. 264 (1989) 5121-5127
194. Wysocka J., Allis C.D., and Coonrod S. Histone arginine methylation and its dynamic regulation. Front. Biosci. 11 (2006) 344-355
195. Wysocka J., Milne T.A., and Allis C.D. Taking LSD 1 to a new high. Cell 122 (2005) 654-658
196. Xu J., Zhou J.Y., Tainsky M.A., and Wu G.S. Evidence that tumor necrosis factor related apoptosis-inducing ligand induction by 5-Aza-2'-deoxycytidine sensitizes human breast cancer cells to adriamycin. Cancer Res. 67 (2007) 1203-1211
197. Yang X.J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32 (2004) 959-976
198. Yoshida M., Matsuyama A., Komatsu Y., and Nishino N. From discovery to the coming generation of histone deacetylase inhibitors. Curr. Med. Chem. 10 (2003) 2351-2358
199. Zargari M., Allameh A., Sanati M.H., Tiraihi T., Lavasani S., and Emadyan O. Relationship between the clinical scoring and demyelination in central nervous system with total antioxidant capacity of plasma during experimental autoimmune encephalomyelitis development in mice. Neurosci. Lett. 412 (2007) 24-28
200. Zhang Y., and Reinberg D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15 (2001) 2343-2360
201. Zhou S.R., Moscarello M.A., and Whitaker J.N. The effects of citrullination on variable aminoterminus acylation on the encephalitogenicity of human MBP in the Pl?J mouse. J. Neuroimmunol. 62 (1995) 147-152
202. Zivadinov R., Uxa L., Bratina A., Bosco A., Srinivasaraghavan B., Minagar A., Ukmar M., Benedetto S., and Zorzon M. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Int. Rev. Neurobiol. 79 (2007) 521-535